Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,500
Closed -$4K 4431
2022
Q4
$4K Buy
3,500
+1,700
+94% +$2.65K ﹤0.01% 3337
2022
Q3
$3K Hold
1,800
﹤0.01% 3999
2022
Q2
$4K Sell
1,800
-6,000
-77% -$14.4K ﹤0.01% 3887
2022
Q1
$25K Buy
7,800
+1,200
+18% +$4.22K ﹤0.01% 2861
2021
Q4
$30K Buy
6,600
+3,700
+128% +$27.9K ﹤0.01% 2803
2021
Q3
$20K Sell
2,900
-4,724
-62% -$34.7K ﹤0.01% 3344
2021
Q2
$61K Sell
7,624
-1,712
-18% -$14.4K ﹤0.01% 2319
2021
Q1
$63K Buy
+9,336
New +$62.1K ﹤0.01% 2157

Other funds holding OCGN

Cutler Group's OCGN Position: Q1 2023 in Review

Cutler Group sold out of Ocugen (OCGN) in Q1 2023, closing a stake of 3,500 shares — an estimated $4K sold.

Cutler Group first reported a position in OCGN in Q1 2021 and held it in 8 quarters. The position peaked at $63K in Q1 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • Cutler Group reported no remaining Ocugen position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 3,500 Ocugen shares in Q1 2023, an estimated $4K.
  • Cutler Group first reported a position in Ocugen in Q1 2021 and held it in 8 quarters.
  • Cutler Group's Ocugen position peaked at $63K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.